
Alterity Therapeutics Ltd (ATHE)
US$ 4.25-5.76%
Price Chart
Key Statistics
Market Cap
$ 79.84M
P/E Ratio
0.00
Revenue (TTM)
$ 3.72M
Volume
160.48K
52W High
$ 7.00
52W Low
$ 1.00
Dividend Yield
0.00%
Beta
0.71
Technicals
50-Day MA
4.5618
200-Day MA
3.3543
52 Week High
7
52 Week Low
1.001
About ATHE
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Au.
Employees
10
Headquarters
Melbourne, VIC
CEO
Mr. Geoffrey Paul Kempler B.Sc.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg